Literature DB >> 29308715

Exploring the relationship between vitamin D and mania: correlations between serum vitamin D levels and disease activity.

Neslihan Altunsoy1, Rabia Nazik Yüksel1, Merve Cingi Yirun1, Ayşegül Kılıçarslan2, Çiğdem Aydemir1.   

Abstract

BACKGROUND: Several studies suggest an association between hypovitaminosis D and mood disorders including major depressive disorder, seasonal affective disorder and premenstrual dysphoric disorder. On the other hand, there is not enough study about acute manic episode and hypovitaminosis D. This data insufficient zone led us to study on whether vitamin D deficiency is associated with acute manic episode and has an impact on disease activity
Methods: Thirty-one patients with bipolar disorder in remission, 26 patients with acute manic episode and 40 healthy controls with no major psychopathology were recruited in this study. Hamilton Depression Rating Scale (HAM-D), Young Mania Rating Scale (YMRS) and the Clinical Global Impression - Severety scale (CGI-S) were used to evaluate disease activity. Total vitamin D (D2 + D3) values were measured.
RESULTS: Patients in acute manic episode had significantly lower (p = .002) vitamin D serum concentrations than healthy controls (respectively 15.16 ± 7.48 and 22.31 ± 8.8) but remission group's serum concentrations (18.40 ± 7.30) did not differ significantly from healthy controls or acute manic episode patients (p > .05). We observed negative and moderate correlations between vitamin D levels and YMRS scores (r: -0.641, p < .001), vitamin D levels and CGI scores (r: -0.559, p= .003).
CONCLUSIONS: Our results contribute to the idea that vitamin D deficiency and acute manic episode may have interactions with many pathways. Future trials may investigate this association with longer follow up. We recommend that serum vitamin D levels should be measured in patients with bipolar disorder especially in long term care.

Entities:  

Keywords:  25-OH vitamin D; Bipolar disorder; acute manic episode; vitamin D; vitamin D deficiency

Mesh:

Substances:

Year:  2018        PMID: 29308715     DOI: 10.1080/08039488.2018.1424238

Source DB:  PubMed          Journal:  Nord J Psychiatry        ISSN: 0803-9488            Impact factor:   2.202


  5 in total

1.  [Bipolar disorder vulnerability: The vitamin D path].

Authors:  Manel Naifar; Manel Maalej Bouali; Wassim Guidara; Ahmed Slim Ellouze; Khalil Jmal; Sana Omri; Meriam Messedi; Lobna Zouari; Aida Elleuch; Mohamed Maalej; Khansa Chaabouni; Nada Charfi; Mouna Turki; Ben Thabet Jihène; Fatma Ayadi
Journal:  Can J Psychiatry       Date:  2019-08-21       Impact factor: 4.356

Review 2.  Targeting Mitochondrial Dysfunction for Bipolar Disorder.

Authors:  Maya Kuperberg; Sophie L A Greenebaum; Andrew A Nierenberg
Journal:  Curr Top Behav Neurosci       Date:  2021

3.  Vitamin D levels in patients with recurrent aphthous stomatitis.

Authors:  Aynure Öztekin; Coşkun Öztekin
Journal:  BMC Oral Health       Date:  2018-11-09       Impact factor: 2.757

4.  Diagnostic difficulties in the diagnosis of high acute-phase proteins levels in a teenage drug addicted female patient.

Authors:  Helena Krakowczyk; Maria Szczepańska; Urszula Wróblowska-Grzonka; Katarzyna Gajewska-Ormińska; Katarzyna Ziora; Edyta Machura
Journal:  BMC Psychiatry       Date:  2022-07-28       Impact factor: 4.144

Review 5.  Therapeutic approaches employing natural compounds and derivatives for treating bipolar disorder: emphasis on experimental models of the manic phase.

Authors:  Vânia Machado Recart; Luiza Spohr; Mayara Sandrielly Pereira Soares; Karina Pereira Luduvico; Francieli Moro Stefanello; Roselia Maria Spanevello
Journal:  Metab Brain Dis       Date:  2021-07-15       Impact factor: 3.584

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.